Skip to content
Wholesale trade
KZActiveBIN 081040005097
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 17
To risks

ТОО "BIOVITRUM ASTANA" (БИОВИТРУМ АСТАНА)

Director
Канапьянова Арман Сапаровна
Incorporated
08.10.2008
Address
Астана ул. МӘСКЕУ, зд. 40
РНН
620300312245

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/17

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "BIOVITRUM ASTANA" (БИОВИТРУМ АСТАНА)
BIN
081040005097
Status
Active
Director
Канапьянова Арман Сапаровна
Registration date
08.10.2008
Activity
Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями
Legal address
Астана ул. МӘСКЕУ, зд. 40

In government contracts over 2 years

VAT payer
Yes, since 10.10.2008
КАТО
711310000
РНН
620300312245
КФС
Собственность иностранных юридических лиц
КСЕ
Нефинансовые корпорации под иностранным контролем – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.
Procurement role
Поставщик

Activities

1
46461primary

Оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
41.8M
2025
62.1M+21%
2024
51.2M+0%
2023
51.1M+42%
2022
35.9M+184%
2021
12.7M
·41.8M
2026year to date
+21%62.1M
2025
+0%51.2M
2024
+42%51.1M
2023
+184%35.9M
2022
·12.7M
2021
2026
Tax paid41,832,710 ₸
Penalty2,000 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid62,131,584 ₸
Penalty0 ₸
Fine27,524 ₸
VAT refund0 ₸
2024
Tax paid51,221,000 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
2023
Tax paid51,079,057 ₸
Penalty67,675 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid35,915,296 ₸
Penalty27,000 ₸
Fine0 ₸
VAT refund0 ₸
2021
Tax paid12,665,553 ₸
Penalty2,000 ₸
Fine0 ₸
VAT refund0 ₸
Estimated taxable profit

Estimate: corporate income tax ÷ 0%. Not a filing and not revenue — the taxable profit implied by the corporate income tax paid. Actual profit differs by deductions, carried-forward losses and reduced rates.

Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

1
  • КА

    Канапьянова Арман Сапаровна

    Director

Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

ТОО "BIOVITRUM ASTANA" (БИОВИТРУМ АСТАНА) (BIN 081040005097) is an active legal entity in Астана, registered in 2008 (18 years on the market). Primary activity — оптовая торговля фармацевтическими товарами, кроме торговли медицинской техникой и ортопедическими изделиями. Per open government registries as of November 7, 2026: 607 government contracts on Портал государственных закупок РК (goszakup.gov.kz) worth 880,062,609 ₸. Automated screening of open registries found no risk indicators for "BIOVITRUM ASTANA". Director on record — Канапьянова Арман Сапаровна. Data current as of November 7, 2026.

Information is aggregated from open government registries of Kazakhstan: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is indexed automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the corresponding facts. This is reference information and does not replace an official extract. Learn more about the methodology and sources — SafeDeal editorial policy.